September 8th, 2020Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas https://clinicaltrials.gov/ct2/show/NCT03715933?term=DR5+INBRX109&rank=1 Go to Arm Intervention/treatment Experimental: Dose...
Read ArticleSeptember 5th, 2020Hello my CS brothers and sisters! I wanted to tell you a story about my journey which might help some of you. Here are some details: --diagnosed in Feb 2017, Grade 1 pelvic CS, spread widely on and around the acetabulum. Offered a hemipelvectomy...
Read ArticleSeptember 3rd, 2020A CS Warrior on the Facebook Chondrosarcoma Support Group entered a new Phase 2 clinical trial yesterday specifically for unresectable and metastatic conventional CS that combines a histone deacetylase inhibitor Belinostat (FDA approved for a type...
Read ArticleSeptember 2nd, 2020In September, we honor the gold ribbon in recognition of Childhood Cancer Awareness Month! ✨ Did you know cancer is the second leading cause of death in children under the age of 15? In 2020, approximately 11,000 children ages 1-14 will be...
Read ArticleSeptember 2nd, 2020Testing the Combination of Belinostat and SGI-110 (Guadecitabine) for the Treatment of Unresectable and Metastatic Conventional Chondrosarcoma clinicaltrials.gov Brief Summary: This phase II trial studies how well belinostat and SGI-110...
Read ArticleAugust 31st, 2020 To view the video on YouTube, click here
Read ArticleAugust 29th, 2020Schwartz Hunts for Predictive Biomarkers in Soft Tissue Sarcoma Gary K. Schwartz, MD, highlights research that is being done with regard to genomic signatures in sarcoma, challenges faced with immunotherapy, and where the field is headed. Gary K....
Read ArticleAugust 16th, 2020Targeting the Multidrug Transporter Ptch1 Potentiates Chemotherapy Efficiency Abstract One of the crucial challenges in the clinical management of cancer is resistance to chemotherapeutics. Multidrug resistance (MDR) has been intensively studied,...
Read Article